1.
Ross DM, Bartley PA, Goyne J, Morley AA, Seymour JF, Grigg AP. Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease features. Haematologica 2011; 96(11):1720-1722; https://doi.org/10.3324/haematol.2011.048165.